Daniella Furtado

Brigham and Women's Hospital

Papers

1

Total Citations

2

H-Index

1

About

Daniella Furtado is a pioneering researcher in interventional oncology, with a focused expertise in precision medicine for prostate cancer. Her work centers on developing novel, minimally invasive techniques to personalize cancer treatment, particularly through the integration of advanced imaging and localized drug delivery. Her major contribution is the proof-of-concept for an implantable microdevice (IMD) that can be placed directly into prostate tumors under MRI guidance. This device simultaneously tests multiple systemic therapy agents *in situ*, allowing for real-time assessment of individual tumor drug sensitivity before committing a patient to a full course of systemic treatment. This groundbreaking approach, detailed in her 2024 paper, has already garnered 2 citations and represents a paradigm shift toward "smart" biopsies. By enabling personalized drug selection from within the tumor microenvironment, Furtado’s work promises to reduce ineffective treatments and their associated toxicities, marking a significant leap forward in the fight against intermediate-risk and high-risk prostate cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Novel Intraprostatic MR-Guided Implantation of Multidrug-Eluting Microdevice for Testing of Systemic Therapy Agents In Situ: Proof of Concept in Intermediate-Risk and High-Risk Prostate Cancer
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Brigham and Women's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago